Atria Investments LLC Gilead Sciences, Inc. Transaction History

Atria Investments LLC

  • $7.49 Billion
  • Q4 2024

A detailed history of Atria Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 67,383 shares of GILD stock, worth $7.01 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
67,383
Previous 82,645 18.47%
Holding current value
$7.01 Million
Previous $6.93 Million 10.15%
% of portfolio
0.08%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$83.95 - $97.9 $1.28 Million - $1.49 Million
-15,262 Reduced 18.47%
67,383 $6.22 Million
Q3 2024

Nov 01, 2024
SELL
$66.59 - $83.99 $256,637 - $323,697
-3,854 Reduced 4.46%
82,645 $6.93 Million
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $190,460 - $219,806
-3,016 Reduced 3.37%
86,499 $5.93 Million
Q1 2024

May 21, 2024
BUY
$71.58 - $87.29 $895,251 - $1.09 Million
12,507 Added 16.24%
89,515 $6.56 Million
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $306,415 - $347,482
4,182 Added 5.74%
77,008 $6.24 Million
Q3 2023

Nov 07, 2023
SELL
$73.94 - $80.67 $35,860 - $39,124
-485 Reduced 0.66%
72,826 $5.46 Million
Q2 2023

Aug 04, 2023
SELL
$76.01 - $86.7 $550,844 - $628,314
-7,247 Reduced 9.0%
73,311 $5.65 Million
Q1 2023

May 10, 2023
SELL
$77.31 - $88.08 $2.57 Million - $2.92 Million
-33,190 Reduced 29.18%
80,558 $6.68 Million
Q4 2022

Jan 31, 2023
SELL
$62.32 - $89.47 $471,263 - $676,572
-7,562 Reduced 6.23%
113,748 $9.77 Million
Q3 2022

Nov 01, 2022
BUY
$59.54 - $68.01 $525,619 - $600,392
8,828 Added 7.85%
121,310 $7.48 Million
Q2 2022

Aug 11, 2022
BUY
$57.72 - $65.01 $1.25 Million - $1.4 Million
21,602 Added 23.77%
112,482 $6.95 Million
Q1 2022

May 02, 2022
BUY
$57.92 - $72.58 $908,996 - $1.14 Million
15,694 Added 20.87%
90,880 $5.4 Million
Q4 2021

Feb 04, 2022
BUY
$64.88 - $73.64 $51,709 - $58,691
797 Added 1.07%
75,186 $5.46 Million
Q3 2021

Nov 16, 2021
BUY
$67.69 - $73.03 $89,012 - $96,034
1,315 Added 1.8%
74,389 $5.2 Million
Q2 2021

Aug 10, 2021
BUY
$63.47 - $69.35 $185,649 - $202,848
2,925 Added 4.17%
73,074 $5.03 Million
Q1 2021

May 11, 2021
BUY
$60.0 - $68.46 $442,800 - $505,234
7,380 Added 11.76%
70,149 $4.53 Million
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $909,175 - $1.04 Million
16,049 Added 34.35%
62,769 $3.66 Million
Q3 2020

Nov 05, 2020
SELL
$62.1 - $78.08 $2.83 Million - $3.56 Million
-45,649 Reduced 49.42%
46,720 $2.95 Million
Q2 2020

Sep 22, 2020
BUY
$72.34 - $84.0 $6.68 Million - $7.76 Million
92,369 New
92,369 $7.11 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $2.55 Million - $3.26 Million
-40,658 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$61.62 - $67.78 $437,009 - $480,695
7,092 Added 21.13%
40,658 $2.64 Million
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $113,268 - $125,028
-1,812 Reduced 5.12%
33,566 $2.13 Million
Q2 2019

Aug 26, 2019
BUY
$61.87 - $69.38 $2.19 Million - $2.45 Million
35,378 New
35,378 $2.24 Million
Q2 2019

Aug 09, 2019
SELL
$61.87 - $69.38 $946,054 - $1.06 Million
-15,291 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $162,077 - $181,569
2,592 Added 20.41%
15,291 $994,000
Q4 2018

Feb 12, 2019
SELL
$60.54 - $79.0 $1.62 Million - $2.12 Million
-26,786 Reduced 67.84%
12,699 $794,000
Q3 2018

Oct 09, 2018
SELL
$71.28 - $78.92 $465,173 - $515,031
-6,526 Reduced 14.18%
39,485 $3.05 Million
Q2 2018

Jul 13, 2018
SELL
$64.88 - $75.68 $1.33 Million - $1.55 Million
-20,520 Reduced 30.84%
46,011 $3.26 Million
Q1 2018

Apr 30, 2018
SELL
$72.84 - $88.8 $196,595 - $239,671
-2,699 Reduced 3.9%
66,531 $5.02 Million
Q4 2017

Jan 16, 2018
BUY
$71.15 - $83.52 $3.71 Million - $4.35 Million
52,140 Added 305.09%
69,230 $4.96 Million
Q3 2017

Oct 12, 2017
BUY
$72.11 - $85.47 $1.23 Million - $1.46 Million
17,090
17,090 $1.39 Million

Others Institutions Holding GILD

# of Institutions
2,072
Shares Held
1.02B
Call Options Held
9.63M
Put Options Held
10.2M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $130B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email